The Effects of Ketone Ester Supplementation During a 5 Week Live High, Train Low Altitude Training Camp
NCT ID: NCT06596083
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
18 participants
INTERVENTIONAL
2024-09-10
2024-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Ketone Ester Supplementation on Sleep and Recovery in Hypoxia
NCT06060093
Role of Intermittent Exogenous Ketosis in the Physiological and Muscular Adaptive Response to Endurance Training
NCT05932420
Effect of Exogenous Ketosis During Ultra-endurance Exercise
NCT05407753
Ketone Esters for Optimization of Operator Performance in Hypoxia
NCT07065864
The Effects of Exogenous Ketosis on Ultra-endurance Recovery and Performance
NCT06965491
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will follow a 5 week simulated altitude training camp where they spend 75 hours per week at altitude (2000-3000 meters), while taking ketone or placebo supplements after every training sessions and before going to sleep. During these 5 weeks, they will adhere to a prescribed training plan, consisting of 5 to 7 training sessions per week. Before, after and 1 week after the training camp, their exercise performance, EPO concentrations, hemoglobin mass and VO2max will be tested.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo Comparator
Training intervention: 5 weeks of live high, train low followed by an additional 1 week of reduced training (to simulate preparation for an upcoming event or race) Dietary intervention: placebo supplement
Placebo supplement
oral supplement containing: 16.4 grams of medium chained triglycerides, 1mM or sucrose octaacetate and water
Experimental group
Training intervention: 5 weeks of live high, train low followed by an additional 1 week of reduced training (to simulate preparation for an upcoming event or race) Dietary intervention: Ketone ester supplement
Ketone ester supplement
Oral supplement containing: 25 grams of pure (R)-3-hydroxybutyl-(R)-3-hydroxybutyrate ketone monoester drink
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo supplement
oral supplement containing: 16.4 grams of medium chained triglycerides, 1mM or sucrose octaacetate and water
Ketone ester supplement
Oral supplement containing: 25 grams of pure (R)-3-hydroxybutyl-(R)-3-hydroxybutyrate ketone monoester drink
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good health status confirmed by a medical screening
* Non-smoking
Exclusion Criteria
* Any kind of injury/pathology that is a contra-indication for exposure to hypoxia
* Ongoing pregnancy or breastfeeding
* intake of any medication or nutritional supplement that is proven to affect exercise performance during the last month prior to the start of the study
* Involvement in elite athletic training at a semi-professional or professional level
* Exposure to altitudes higher than 1500 m during the 3 months prior to the start of the study
* Blood ferritin levels below 30 ng/mL
* Current participation in another research trial
* Any other argument to believe that the subject is unlikely to succesfully complete the full study protocol
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chiel Poffé
postdoctoral researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chiel Poffé
Role: PRINCIPAL_INVESTIGATOR
KU Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KU Leuven
Leuven, Vlaams-Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S67562
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.